Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Auranofin is dosed at 0.05–0.2 mg/kg PO q12h in dogs, per Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.144 (2026-08-01).. Auranofin is used in dogs for Pemphigus (adjunctive). Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Auranofin in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Ridaura
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.05–0.2 mg/kg | q12h | Months | Pemphigus (adjunctive) | Weak | Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.144 (2026-08-01). |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Oral gold salt with immunomodulatory and anti-inflammatory properties. Inhibits macrophage and lymphocyte function. Mechanism not fully understood.
Used for immune-mediated skin diseases (pemphigus). Slow onset (weeks to months). Toxicity: diarrhea, proteinuria, bone marrow suppression. Monitor CBC and urinalysis. Largely replaced by newer agents.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Auranofin dose range in dogs, with cited source references: PO 0.05–0.2 mg/kg q12h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Auranofin in dogs: PO.
Cited course lengths for Auranofin in dogs include: Months. Duration depends on the indication — match it to the specific dose rule in the table above.
Auranofin is indicated in dogs for: Pemphigus (adjunctive).
These are general warnings for Auranofin across species; consult the dog dosing table above for species-specific guidance. Used for immune-mediated skin diseases (pemphigus). Slow onset (weeks to months). Toxicity: diarrhea, proteinuria, bone marrow suppression. Monitor CBC and urinalysis. Largely replaced by newer agents.
Why a species-specific page? Auranofin pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.